Mirae Asset Global Etfs Holdings Ltd. Ironwood Pharmaceuticals Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 84,096 shares of IRWD stock, worth $52,139. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84,096
Previous 89,876
6.43%
Holding current value
$52,139
Previous $398,000
69.1%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IRWD
# of Institutions
222Shares Held
166MCall Options Held
11.2MPut Options Held
6.9K-
Black Rock Inc. New York, NY22.9MShares$14.2 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$10.2 Million6.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.7MShares$9.73 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY13.7MShares$8.49 Million0.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.94MShares$6.16 Million0.02% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $95M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...